Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Janux Therapeutics (JANX) Assets Average (2021 - 2025)

Historic Assets Average for Janux Therapeutics (JANX) over the last 5 years, with Q3 2025 value amounting to $1.0 billion.

  • Janux Therapeutics' Assets Average rose 4836.5% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 4836.5%. This contributed to the annual value of $721.0 million for FY2024, which is 9369.83% up from last year.
  • Per Janux Therapeutics' latest filing, its Assets Average stood at $1.0 billion for Q3 2025, which was up 4836.5% from $1.0 billion recorded in Q2 2025.
  • Janux Therapeutics' 5-year Assets Average high stood at $1.1 billion for Q1 2025, and its period low was $347.2 million during Q2 2023.
  • In the last 5 years, Janux Therapeutics' Assets Average had a median value of $385.5 million in 2021 and averaged $568.1 million.
  • Per our database at Business Quant, Janux Therapeutics' Assets Average tumbled by 789.24% in 2023 and then soared by 12893.7% in 2024.
  • Over the past 5 years, Janux Therapeutics' Assets Average (Quarter) stood at $385.5 million in 2021, then decreased by 4.04% to $369.9 million in 2022, then rose by 3.72% to $383.6 million in 2023, then surged by 128.94% to $878.3 million in 2024, then rose by 17.1% to $1.0 billion in 2025.
  • Its last three reported values are $1.0 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.1 billion during Q1 2025.